Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

360

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

360 results for “meningitis”

Learn how ShareScore rates datasets ↗
dryad36/100

Data from: Meningeal-derived retinoic acid regulates neurogenesis via suppression of Notch and Sox2

Open the record for dataset details and reuse information.

publicMar 2025View details →
dryad36/100

Meningeal regulatory T cells inhibit nociception in female mice

Open the record for dataset details and reuse information.

publicMar 2025View details →
dryad36/100

Genotype stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative Adults: the LAST ACT trial

Open the record for dataset details and reuse information.

publicSep 2025View details →
dryad36/100

Using cerebrospinal fluid nanopore sequencing assay to diagnose tuberculous meningitis: a retrospective cohort study in China

Open the record for dataset details and reuse information.

publicMay 2024View details →
dryad36/100

The effect of sertraline on depression and associations with persistent depression in survivors of HIV-related cryptococcal meningitis

Open the record for dataset details and reuse information.

publicJan 2021View details →
dryad32/100

Data from: Single-dose oral ciprofloxacin prophylaxis as a response to a meningococcal meningitis epidemic in the African meningitis belt: a three-arm, open-label, cluster-randomized trial

Background: Antibiotic prophylaxis for contacts of meningitis cases is not recommended during outbreaks in the African meningitis belt. We assessed the effectiveness of single-dose oral ciprofloxacin administered to household contacts and in village-wide distributions on the overall attack rate (AR) in an outbreak of meningococcal meningitis. Methods and findings: In this 3-arm, open-label, cluster-randomized trial during a meningococcal meningitis outbreak in Madarounfa District, Niger, villages notifying a suspected case were randomly assigned (1:1:1) to standard care (the control arm), single-dose oral ciprofloxacin for household contacts within 24 hours of case notification, or village-wide distribution of ciprofloxacin within 72 hours of first case notification. The primary outcome was the overall AR of suspected meningitis after inclusion. A random sample of 20 participating villages was enrolled to document any changes in fecal carriage prevalence of ciprofloxacin-resistant and extended-spectrum beta-lactamase (ESBL)–producing Enterobacteriaceae before and after the intervention. Between April 22 and May 18, 2017, 49 villages were included: 17 to the control arm, 17 to household prophylaxis, and 15 to village-wide prophylaxis. A total of 248 cases were notified in the study after the index cases. The AR was 451 per 100,000 persons in the control arm, 386 per 100,000 persons in the household prophylaxis arm (t test versus control p = 0.68), and 190 per 100,000 persons in the village-wide prophylaxis arm (t test versus control p = 0.032). The adjusted AR ratio between the household prophylaxis arm and the control arm was 0.94 (95% CI 0.52–1.73, p = 0.85), and the adjusted AR ratio between the village-wide prophylaxis arm and the control arm was 0.40 (95% CI 0.19‒0.87, p = 0.022). No adverse events were notified. Baseline carriage prevalence of ciprofloxacin-resistant Enterobacteriaceae was 95% and of ESBL-producing Enterobacteriaceae was >90%, and did not change post-intervention. One limitation of the study was the small number of cerebrospinal fluid samples sent for confirmatory testing. Conclusions: Village-wide distribution of single-dose oral ciprofloxacin within 72 hours of case notification reduced overall meningitis AR. Distributions of ciprofloxacin could be an effective tool in future meningitis outbreak responses, but further studies investigating length of protection, effectiveness in urban settings, and potential impact on antimicrobial resistance patterns should be carried out.

opencc-zeroDec 2017View details →
zenodo32/100

Single Cell Profiling of Human Dura and Meningioma Reveals Cellular Meningeal Landscape and Insights into Meningioma Immune Response

<p>This repository contains the single-cell RNA-seq data described in&nbsp;the publication &ldquo;Single Cell Profiling of Human Dura and Meningioma Reveals Cellular Meningeal Landscape and Insights into Meningioma Immune Response.&rdquo; Data is provided&nbsp;as count matrices and Seurat objects.</p>

opencc-by-4.0Apr 2022View details →
zenodo32/100

7 day clodronate depletion: brain and meninges

<p>These files contain data from mice given either clodronate or saline liposomes i.c.v. Brains and meninges were collected at 7 days post liposome administration and processed for flow cytometry. A workspace file is included to clarify gating and quantification.</p>

opencc-by-4.0Nov 2022View details →
zenodo32/100

CX3CR1 CreERT2 TdTomato Fatemap Recombination for brain, meninges, and blood

<p>These files contain quantification of recombination efficiency in tamoxifen-injected CX3CR1 CreERT2 TdTomato mice. The blood data was acquired longitudinally over six weeks, whereas the brain and meninges data were acquired at the end of the six weeks. Workspace files are included to demonstrate gating and quantification.</p>

opencc-by-4.0Nov 2022View details →
ClinicalTrials.gov32/100

Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine

ClinicalTrials.gov study NCT00074607. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Middle Meningeal Artery (MMA) Embolization Compared to Traditional Surgical Strategies to Treat Chronic Subdural Hematomas (cSDH)

ClinicalTrials.gov study NCT04095819. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Zorifertinib With Osimertinib for NSCLC With Meningeal Progression

ClinicalTrials.gov study NCT07361705. IPD Sharing: NO. Countries: 1. Publications: 19.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer

ClinicalTrials.gov study NCT06431685. IPD Sharing: NO. Countries: 1. Publications: 10.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis

ClinicalTrials.gov study NCT00000708. IPD Sharing: Not stated. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study

ClinicalTrials.gov study NCT02169882. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis

ClinicalTrials.gov study NCT02136030. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis

ClinicalTrials.gov study NCT00976040. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Treatment With Tamoxifen in Cryptococcal Meningitis

ClinicalTrials.gov study NCT03112031. IPD Sharing: UNDECIDED. Countries: 1. Publications: 57.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis

ClinicalTrials.gov study NCT04145258. IPD Sharing: Not stated. Countries: 4. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study

ClinicalTrials.gov study NCT01158755. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record